Abiopharma

News list

📋 SUSHIL PATEL (Director) plans to sell 6K shares of Revolution Medicines, Inc. (at $182.08 each, total $1.0M) Filed: Jun 29, 2026 | ID: 006611

Full text

News bot June 29, 2026, 8:45 p.m.
📋 Form 144 Filing: SUSHIL PATEL

Company: Revolution Medicines, Inc.

Filing Date: 2026-06-29

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 5,580
- Price per Share: $182.08
- Total Value: $1,016,006.40
- Planned Sale Date: 2026-06-29
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39219
- Issuer Contact Phone: 6504816801
- Issuer Address: 700 Saginaw Drive, Redwood City, CA, 94063
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 212596462.0
- Number of Securities to be Sold: 2
- Remarks: The securities to be sold were acquired upon the vesting of restricted stock units during the period of 06/15/2024 through 12/15/2024.
- Signature: /s/ Sushil Patel